170 related articles for article (PubMed ID: 38376366)
1. Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein.
Huang Y; Huang C; Chen J; Chen S; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
Microbiol Spectr; 2024 Apr; 12(4):e0341023. PubMed ID: 38376366
[TBL] [Abstract][Full Text] [Related]
2. The Nucleocapsid Proteins of SARS-CoV-2 and Its Close Relative Bat Coronavirus RaTG13 Are Capable of Inhibiting PKR- and RNase L-Mediated Antiviral Pathways.
LeBlanc K; Lynch J; Layne C; Vendramelli R; Sloan A; Tailor N; Deschambault Y; Zhang F; Kobasa D; Safronetz D; Xiang Y; Cao J
Microbiol Spectr; 2023 Jun; 11(3):e0099423. PubMed ID: 37154717
[TBL] [Abstract][Full Text] [Related]
3. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.
Zhao M; Yu Y; Sun LM; Xing JQ; Li T; Zhu Y; Wang M; Yu Y; Xue W; Xia T; Cai H; Han QY; Yin X; Li WH; Li AL; Cui J; Yuan Z; Zhang R; Zhou T; Zhang XM; Li T
Nat Commun; 2021 Apr; 12(1):2114. PubMed ID: 33837182
[TBL] [Abstract][Full Text] [Related]
4. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
[TBL] [Abstract][Full Text] [Related]
5. Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates.
Chen Y; Lei X; Jiang Z; Humphries F; Parsi KM; Mustone NJ; Ramos I; Mutetwa T; Fernandez-Sesma A; Maehr R; Caffrey DR; Fitzgerald KA
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2308355120. PubMed ID: 37963251
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery.
Royster A; Ren S; Ma Y; Pintado M; Kahng E; Rowan S; Mir S; Mir M
Microbiol Spectr; 2023 Jun; 11(3):e0118623. PubMed ID: 37199631
[TBL] [Abstract][Full Text] [Related]
7. Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex.
Cai S; Zhang C; Zhuang Z; Zhang S; Ma L; Yang S; Zhou T; Wang Z; Xie W; Jin S; Zhao J; Guan X; Wu J; Cui J; Wu Y
Signal Transduct Target Ther; 2023 Apr; 8(1):170. PubMed ID: 37100798
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
[TBL] [Abstract][Full Text] [Related]
9. Contributions of the N-terminal intrinsically disordered region of the severe acute respiratory syndrome coronavirus 2 nucleocapsid protein to RNA-induced phase separation.
Zachrdla M; Savastano A; Ibáñez de Opakua A; Cima-Omori MS; Zweckstetter M
Protein Sci; 2022 Sep; 31(9):e4409. PubMed ID: 36040256
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic and thermodynamic characterization of antiviral inhibitors targeting nucleocapsid N-terminal domain of SARS-CoV-2.
Dhaka P; Singh A; Choudhary S; Peddinti RK; Kumar P; Sharma GK; Tomar S
Arch Biochem Biophys; 2023 Dec; 750():109820. PubMed ID: 37956938
[TBL] [Abstract][Full Text] [Related]
11. Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.
Iserman C; Roden CA; Boerneke MA; Sealfon RSG; McLaughlin GA; Jungreis I; Fritch EJ; Hou YJ; Ekena J; Weidmann CA; Theesfeld CL; Kellis M; Troyanskaya OG; Baric RS; Sheahan TP; Weeks KM; Gladfelter AS
Mol Cell; 2020 Dec; 80(6):1078-1091.e6. PubMed ID: 33290746
[TBL] [Abstract][Full Text] [Related]
12. Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.
Chau BA; Chen V; Cochrane AW; Parent LJ; Mouland AJ
Cell Rep; 2023 Jan; 42(1):111968. PubMed ID: 36640305
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.
Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q
mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567
[TBL] [Abstract][Full Text] [Related]
14. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.
Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ
Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047
[TBL] [Abstract][Full Text] [Related]
15. TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.
Ren J; Wang S; Zong Z; Pan T; Liu S; Mao W; Huang H; Yan X; Yang B; He X; Zhou F; Zhang L
Nat Commun; 2024 Jan; 15(1):244. PubMed ID: 38172120
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Activity of Cinchona officinalis, a Homeopathic Medicine, against COVID-19.
Arumugam S; Vadivel K; Dhaked DK; Prasanna VS; Yellurkar ML; Das P; Manoharan R; Thomas AJ; Singh L; Singh S; Velayutham R
Homeopathy; 2024 Feb; 113(1):16-24. PubMed ID: 37673083
[TBL] [Abstract][Full Text] [Related]
17. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
[TBL] [Abstract][Full Text] [Related]
18. Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development.
de Almeida MT; Barbosa AP; Bomfim CG; Visnardi AB; Vinces TC; Ceroni A; Durigon EL; Guzzo CR
J Immunol Methods; 2023 Nov; 522():113558. PubMed ID: 37704125
[TBL] [Abstract][Full Text] [Related]
19. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development.
Yu H; Guan F; Miller H; Lei J; Liu C
Emerg Microbes Infect; 2023 Dec; 12(1):e2164219. PubMed ID: 36583642
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
Mohammed MEA
Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
